Table 1 Baseline characteristics of subjects with and without DM
|  | All (n = 456) | Without DM (n = 334) | With DM (n = 122) | p |
|---|---|---|---|---|
Age (years) | 64 ± 14 | 64 ± 15 | 66 ± 12 | 0.15 |
Men, n (%) | 261 (57) | 182 (54) | 79 (65) | 0.04 |
Body mass index (kg/m2) | 23 ± 4 | 23 ± 3 | 25 ± 4 | <0.01 |
Waist circumference (cm) | 84 ± 11 | 82 ± 10 | 88 ± 11 | <0.01 |
Subcutaneous adipose tissue (cm2) | 136 ± 79 | 132 ± 76 | 147 ± 84 | 0.08 |
Visceral adipose tissue (cm2) | 95 ± 55 | 88 ± 52 | 116 ± 58 | <0.01 |
Hypertension, n (%) | 263 (58) | 176 (53) | 87 (71) | <0.01 |
Dyslipidemia, n (%) | 208 (46) | 130 (39) | 78 (66) | <0.01 |
Current smoking, n (%) | 98 (21) | 72 (22) | 26 (21) | 0.96 |
Total cholesterol (mg/dl) | 187 ± 37 | 188 ± 38 | 187 ± 36 | 0.95 |
Triglycerides (mg/dl) | 143 (88) | 138 (107) | 154 (121) | 0.02 |
HDL-cholesterol (mg/dl) | 57 ± 16 | 58 ± 16 | 56 ± 17 | 0.16 |
LDL-cholesterol (mg/dl) | 111 ± 32 | 111 ± 33 | 110 ± 30 | 0.93 |
Hemoglobin A1c (%) | 6.2 ± 1.2 | 5.7 ± 0.4 | 7.4 ± 1.6 | <0.01 |
High sensitivity CRP (mg/dl) | 0.16 (0.08) | 0.15 (0.08) | 0.17 (0.09) | 0.30 |
Medications | Â | Â | Â | Â |
Antihypertensive agents, n (%) | 239 (52) | 160 (48) | 79 (65) | <0.01 |
Lipid lowering agents n (%) | 138 (30) | 84 (25) | 54 (44) | <0.01 |
Hypoglycemic agents, n (%) | 82 (18) | 0 (0) | 82 (67) | <0.01 |